Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00

Дата публикации: 10-08-2026 05:48:47

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $145.00 to $146.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other analysts have also recently commented on the company. Canaccord Genuity Group set […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
2	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
3	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
4	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
5	Natera (NASDAQ:NTRA) Price Target Raised to $360.00	0	14.27	10-08-2026
6	Allient (NASDAQ:ALNT) Price Target Raised to $120.00	0	13.06	10-08-2026
7	Odyssey Therapeutics (NASDAQ:ODTX) Price Target Raised to $29.00	0	14.24	10-08-2026
8	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
9	Qiagen (NYSE:QGEN) Price Target Raised to $50.00	0	14.26	10-08-2026
10	Lamar Advertising (NASDAQ:LAMR) Price Target Raised to $160.00	0	14.24	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.22. Источник: www.americanbankingnews.com.